Main page content

Displaying results 21 - 30 of 40
Publication ID: PEP20-03-02-001
Published:

The EAP Prescription Drug Toolkit and Fact Sheets provide guidance related to counseling, referrals, and follow-up services (e.g., alternatives to prescription drugs, workplace drug misuse and relapse prevention, dangers of combined drug use, screenings, and evaluations before returning to work).

Publication ID: PEP20-06-03-001
Published:

This guide reviews interventions for people living with substance use and mental disorders who are at risk for or living with HIV. Selected interventions are in alignment with goals of the federal “Ending the HIV Epidemic: A Plan for America” (EHE) initiative.

Publication ID: PEP19-02-01-003
Published:

This updated TIP includes the latest evidence on motivation-enhancing approaches and strategies. It describes how substance use disorder treatment providers can use these approaches and strategies to increase participation and retention in substance use disorder treatment.

Publication ID: PEP18-TREATMENT-LOCS
Published:

Esta hoja informativa se puede usar como una guía para las personas que buscan tratamiento de salud mental. Ofrece tres pasos necesarios para llevar a cabo antes de utilizar un centro de tratamiento, así como las cinco señales de un centro de tratamiento de calidad, que incluye revisar la acreditación, la medicación, las prácticas basadas en la evidencia, el papel de las familias y las redes de apoyo.

Publication ID: PEP18-TREATMENT-LOC
Published:

This fact sheet serves as a guide for individuals seeking behavioral health treatment. It provides three necessary steps to complete prior to utilizing a treatment center and the five signs of a quality treatment center, which include a review of the accreditation, medication, evidence-based practices, position on the role of families, and support networks.

Publication ID: SMA17-5044
Published:

This report presents 2016 national estimates of use of alcohol, tobacco products, illicit drugs (such as, marijuana, cocaine, heroin, hallucinogens, and inhalants, as well as the misuse of opioids, prescription pain relievers, tranquilizers, stimulants, and sedatives), substance use disorders, and substance use treatment among people 12 years of age and older. It Includes national estimates of any mental illness, serious mental illness, major depressive episode, use of mental health services and suicidal ideation among adults ages 18 or older and national estimates of major depressive episode, use of mental health services among adolescents aged 12 to 17. Trend information on these topics are also presented.

Publication ID: SMA16-4977
Published:

This advisory discusses the interaction between obsessive-compulsive disorder (OCD) and substance use disorder. It provides clinicians with an overview of screening and evidence-based treatments for OCD.

Publication ID: SMA16-4989
Published:

This guide explores barriers to accessing substance use disorder and mental health treatment services in rural communities, and the benefits of telehealth for these communities. It assists practitioners with implementing telehealth technologies as a means to increase access to services.

Publication ID: SMA16-4999
Published:

The report highlights the need for HIV treatment providers to address behavioral health concerns with HIV. The report urges providers to start with screening for mental health and substance use disorders, and offers strategies for providers to implement screening practices.

Publication ID: SMA16-4990
Published:

This executive summary of the Surgeon General's Report on Alcohol, Drugs, and Health addresses alcohol, illicit drugs, and prescription drug misuse in the United States. Chapters of the report cover neurobiology, prevention, treatment, recovery, health systems integration, and recommendations for the future.

Displaying 21 - 30 out of 40